1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells

1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells

Bibliographic Details
Main Authors:	Scott Garforth, Harris Goldstein, Steven Almo, Christopher R Hiner
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation
by: Yu Wang, et al.
Published: (2024-01-01)

Circulating gluten‐specific, but not CMV‐specific, CD39+ regulatory T cells have an oligoclonal TCR repertoire
by: Laura Cook, et al.
Published: (2020-01-01)

295 Novel T-cell immunotherapeutics enable the selective generation of more potently cytotoxic CD19 chimeric antigen receptor T-cells (CAR-T cells) from CMV-specific cytotoxic T-cells
by: Scott Garforth, et al.
Published: (2023-11-01)

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1-Infected Individuals.
by: Maximilian C Aichelburg, et al.
Published: (2015-01-01)

Cytomegalovirus (CMV) epitope-specific CD4(+) T cells are inflated in HIV(+) CMV(+) subjects
by: Abana, CO, et al.
Published: (2017)

Major TCR repertoire perturbation by immunodominant HLA-B*44:03-restricted CMV-specific T cells
by: Attaf, M, et al.
Published: (2018)

Major TCR Repertoire Perturbation by Immunodominant HLA-B*44:03-Restricted CMV-Specific T Cells
by: Meriem Attaf, et al.
Published: (2018-11-01)

Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors
by: Alonso Corona, et al.
Published: (2009-08-01)

CMV Infection and CMV-Specific Immune Reconstitution Following Haploidentical Stem Cell Transplantation: An Update
by: Xiao-Hua Luo, et al.
Published: (2021-10-01)

Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells
by: Sarah E. Jackson, et al.
Published: (2017-06-01)

Rapid identification of CMV-specific TCRs via reverse TCR cloning system based on bulk TCR repertoire data
by: Cheol-Hwa Hong, et al.
Published: (2022-11-01)

The hallmarks of CMV-specific CD8 T-cell differentiation.
by: Van Den Berg, S, et al.
Published: (2019)

Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
by: Thomas Widmann, et al.
Published: (2008-01-01)

Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine
by: Min Guan, et al.
Published: (2022-06-01)

Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant
by: Taeeun Kim, et al.
Published: (2020-03-01)

1222 Antigen-specific delivery of TCR and costimulatory signals by a protein scaffold selectively activates and markedly expands naïve MART-1-specific CD8+ T cells
by: Scott Garforth, et al.
Published: (2023-11-01)

Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selectively eliminate carcinoma cells
by: Isabel Britsch, et al.
Published: (2023-12-01)

CMV-Specific Cell-Mediated Immunity in Immunocompetent Adults with Primary CMV Infection: A Case Series and Review of the Literature
by: Angela Chiereghin, et al.
Published: (2021-05-01)

In Vitro Evaluation of CMV Specific CD8+T Cells Function in CMV+ Colorectal Cancer Patients Compared to Healthy Controls
by: Mona Shaker Ardakani, et al.
Published: (2019-08-01)

Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies
by: Nicolle H. R. Litjens, et al.
Published: (2017-09-01)

Tissue-specific control of latent CMV reactivation by regulatory T cells.
by: Maha Almanan, et al.
Published: (2017-08-01)

CMV-specific T-Cells for Treatment of CMV Infection after Hematopoietic Stem Cell Transplantation in a Pediatric Case: First Application in Turkey
by: Sevil Celilova, et al.
Published: (2020-02-01)

S291: LONG-TERM SAFETY AND EFFICACY OF CMV/EBV-SPECIFIC T CELLS FOR CMV AND EBV CO-REACTIVATION AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION
by: Pei Xuying, et al.
Published: (2023-08-01)

Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells
by: Helen M McGuire, et al.
Published: (2020-01-01)

Why CMV is a candidate for elimination and then eradication
by: Paul D. Griffiths, et al.
Published: (2016-07-01)

Tissue maintenance of CMV-specific inflationary memory T cells by IL-15.
by: Nicolas S Baumann, et al.
Published: (2018-04-01)

Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies
by: Belén Blanco, et al.
Published: (2020-08-01)

Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors.
by: Nina Loeth, et al.
Published: (2012-01-01)

Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
by: Vanessa Wiening, et al.
Published: (2021-01-01)

Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update
by: Katya Prakash, et al.
Published: (2021-05-01)

Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse
by: Xiao-Hua Luo, et al.
Published: (2023-02-01)

CMV-specific and non-specific CD8+T-cells display an altered phenotype in Wegener's granulomatosis.
by: Lamprecht, P, et al.
Published: (2003)

CMV-specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies
by: Corinne J Smith, et al.
Published: (2016-09-01)

Corrigendum: Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: impact of CMV infection and leukemia relapse
by: Xiao-Hua Luo, et al.
Published: (2023-05-01)

Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
by: Barbara Couturaud, et al.
Published: (2023-11-01)

Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel Disease
by: Paul V. Lehmann, et al.
Published: (2012-04-01)

Impact of CMV Infection on Natural Killer Cell Clonal Repertoire in CMV-Naïve Rhesus Macaques
by: Lauren L. Truitt, et al.
Published: (2019-10-01)

Early primed KLRG1- CMV-specific T cells determine the size of the inflationary T cell pool.
by: Nicolas S Baumann, et al.
Published: (2019-05-01)

Alterations in the phenotype of CMV-specific and total CD8+ T-cell populations in Wegener's granulomatosis.
by: Lamprecht, P, et al.
Published: (2003)

Effect of Type of Dialysis on CMV-Specific CD8+ T Cells in Kidney Transplant Candidates
by: Jose Ramón Vidal-Castiñeira, et al.
Published: (2019-07-01)